The Use of Angiotensin II for Vasodilatory Shock in a Jehovah’s Witness Patient Undergoing Thoracic Surgery: A Case Report

Connie J Lin, Kyung-Min Lee, Silviu C Diaconu, Gregory D Trachiotis and Eric R Heinz

Department of Anesthesiology and Critical Care Medicine, The George Washington University Hospital, USA
Department of Cardiothoracic Surgery, The George Washington University Hospital, USA

^*Correspondance to: Eric R Heinz 

 PDF  Full Text Case Report | Open Access

Abstract:

Perioperative management of shock can present a major anesthetic challenge in critically ill patients as prolonged hypotension can lead to multi-system organ failure and death. Despite standard therapy of fluid resuscitation, and administration of catecholaminergic vasopressors and vasopressin to maintain blood pressure goals, the morbidity and mortality of patients with shock remains high. We report the successful use of perioperative Angiotensin II as monotherapy for a patient with vasodilatory shock who was at high risk for adverse events with the standard management of fluid resuscitation and catecholaminergic vasopressor therapy.

Keywords:

Cite the Article:

Lin CJ, Lee K-M, Diaconu SC, Trachiotis GD, Heinz ER. The Use of Angiotensin II for Vasodilatory Shock in a Jehovah’s Witness Patient Undergoing Thoracic Surgery: A Case Report. World J Surg Surgical Res. 2019; 2: 1161..